Examkin

Soru

Zorluk: Çok zorHealth, Nutrition, and Disease

Match each specific infectious agent (left) with its correct biological classification and corresponding pharmacological treatment mechanism (right).

  • *Streptococcus pneumoniae*A prokaryotic organism capable of independent reproduction; highly susceptible to antibiotics that inhibit peptidoglycan cell wall synthesis.
  • *Influenza A* virusAn acellular agent lacking independent ribosomes; entirely unresponsive to antibiotics but may be managed with specific viral enzyme inhibitors.
  • *Plasmodium falciparum*A unicellular eukaryotic parasite transmitted by an insect vector; treated with medications that disrupt its metabolic processes within human erythrocytes.
  • *Trichophyton rubrum*A eukaryotic organism with a chitin-based cell wall; infections are effectively treated with agents that inhibit ergosterol synthesis in the cell membrane.

Cevap

Streptococcus pneumoniae matches with the prokaryotic organism susceptible to cell wall inhibitors; Influenza A matches with the acellular agent unresponsive to antibiotics; Plasmodium falciparum matches with the unicellular eukaryotic parasite in erythrocytes; Trichophyton rubrum matches with the eukaryotic organism treated with ergosterol inhibitors.
Correctly identifying the biological domain of a pathogen (bacterium, virus, protozoan, fungus) directly determines the appropriate pharmacological treatment, as medications must target structures unique to the infectious agent without harming human host cells.

Adım Adım Çözüm

1
Classify *Streptococcus pneumoniae* based on its biological domain.
It is identified as a bacterium, which is a prokaryote susceptible to traditional antibiotics targeting the cell wall.
Bacterial infections are the primary target for broad and narrow-spectrum antibiotics.
2
Analyze *Influenza A* virus for its structural and treatment characteristics.
It is an acellular obligate intracellular parasite, meaning it lacks ribosomes and cell walls, rendering all antibiotics completely ineffective.
Distinguishing viral from bacterial treatments is critical in disease management and preventing antibiotic resistance.
3
Identify the nature of *Plasmodium falciparum*.
It is recognized as the protozoan parasite responsible for malaria, infecting human erythrocytes (red blood cells).
Protozoans require specific antiparasitic drugs due to their distinct eukaryotic metabolic pathways.
4
Classify *Trichophyton rubrum* and determine its pharmacological vulnerability.
It is a fungus with a chitin cell wall, treated with antifungals that target ergosterol.
Fungal cells share many eukaryotic features with human cells, so treatments must target unique fungal components like ergosterol to avoid host toxicity.

Anahtar Kavram

Classification of infectious agents and their specific pharmacological treatment mechanisms.
Bu soruyu puanla

Konular

Health, Nutrition, and Disease

Bu konudan daha fazla soru